<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35737276</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2240-2993</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Acta neurologica Belgica</Title><ISOAbbreviation>Acta Neurol Belg</ISOAbbreviation></Journal><ArticleTitle>Granulocyte-colony stimulating factor (G-CSF): an emerging therapeutic approach for amyotrophic lateral sclerosis (ALS).</ArticleTitle><Pagination><StartPage>763</StartPage><EndPage>771</EndPage><MedlinePgn>763-771</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13760-022-01996-z</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by neuronal degeneration and inflammation in the nerves. G-CSF is a 19.6-kDa hematopoietic growth factor which is essential for the proliferation and differentiation of granulocyte hematopoietic progenitors. G-CSF exerts neuroprotective activities by induction of neuronal regeneration, inhibition of neuronal apoptosis, mobilization of Hematopoietic stem cells (HSCs), regulation of pro and anti-inflammatory cytokines, and activation of angiogenesis. Pre-clinical studies have shown significant efficacy of G-CSF therapy in mSOD1<sup>G93A</sup> mice models. G-CSF treatments were able to increase the survival of mice. However, clinical studies on ALS patients failed to clone pre-clinical results. Considering the potential role of G-CSF in nervous system regeneration, this study aimed to comprehensively review the clinical and pre-clinical studies addressing G-CSF in ALS treatment.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s) under exclusive licence to Belgian Neurological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vafaei Mastanabad</LastName><ForeName>Mahsa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Doctor of Saveh Healthcare Network, Saveh, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nooraei</LastName><ForeName>Aref</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Comparative Anatomy and Embryology, School of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan Zadeh Tabatabaei</LastName><ForeName>Mahgol Sadat</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbari Fakhrabadi</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Committee, Medical School, Arak University of Medical Sciences, Arak, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafarzadeh</LastName><ForeName>Faria</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-8412-2405</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnourd, Iran. f.Jafarzadeh@nkums.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Acta Neurol Belg</MedlineTA><NlmUniqueID>0247035</NlmUniqueID><ISSNLinking>0300-9009</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>143011-72-7</RegistryNumber><NameOfSubstance UI="D016179">Granulocyte Colony-Stimulating Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016179" MajorTopicYN="N">Granulocyte Colony-Stimulating Factor</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006412" MajorTopicYN="N">Hematopoietic Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006098" MajorTopicYN="N">Granulocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">Granulocyte-colony stimulating factor (G-CSF)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35737276</ArticleId><ArticleId IdType="doi">10.1007/s13760-022-01996-z</ArticleId><ArticleId IdType="pii">10.1007/s13760-022-01996-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moisse K, Strong MJ (2006) Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta (BBA) Mol Basis Dis 1762(11&#x2013;12):1083&#x2013;1093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.03.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dyke JM, Smit-Oistad IM, Macrander C, Krakora D, Meyer MG, Suzuki M (2016) Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS). Exp Neurol 277:275&#x2013;282</Citation><ArticleIdList><ArticleId IdType="pubmed">26775178</ArticleId><ArticleId IdType="pmc">4762214</ArticleId><ArticleId IdType="doi">10.1016/j.expneurol.2016.01.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Doron-Mandel E, Fainzilber M, Terenzio M (2015) Growth control mechanisms in neuronal regeneration. FEBS Lett 589(14):1669&#x2013;1677</Citation><ArticleIdList><ArticleId IdType="pubmed">25937120</ArticleId><ArticleId IdType="doi">10.1016/j.febslet.2015.04.046</ArticleId></ArticleIdList></Reference><Reference><Citation>VandenBosch LS, Reh TA (eds) (2020) Epigenetics in neuronal regeneration. Seminars in cell &amp; developmental biology. Elsevier, Amsterdam</Citation></Reference><Reference><Citation>Nicola NA, Metcalf D, Matsumoto M, Johnson GR (1983) Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem 258(14):9017&#x2013;9023</Citation><ArticleIdList><ArticleId IdType="pubmed">6190815</ArticleId><ArticleId IdType="doi">10.1016/S0021-9258(18)32158-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider A, Kuhn HG, Sch&#xe4;bitz WR (2005) A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 4(12):1753&#x2013;1757</Citation><ArticleIdList><ArticleId IdType="pubmed">16258290</ArticleId><ArticleId IdType="doi">10.4161/cc.4.12.2213</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293&#x2013;299</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateen FJ, Carone M, Sorenson EJ (2010) Patients who survive 5 years or more with ALS in Olmsted County, 1925&#x2013;2004. J Neurol Neurosurg Psychiatry 81(10):1144&#x2013;1146</Citation><ArticleIdList><ArticleId IdType="pubmed">20627966</ArticleId><ArticleId IdType="doi">10.1136/jnnp.2009.201251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S, Siddique T (2015) Sporadic and hereditary amyotrophic lateral sclerosis (ALS). Biochim Biophys Acta (BBA) Mol Basis Dis 1852(4):679&#x2013;684</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.08.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaplinski A, Yen A, Appel SH (2006) Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry 77(3):390&#x2013;392</Citation><ArticleIdList><ArticleId IdType="pubmed">16484652</ArticleId><ArticleId IdType="pmc">2077717</ArticleId><ArticleId IdType="doi">10.1136/jnnp.2005.072660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169(1&#x2013;2):13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons Z, Felgoise SH, Rodriguez JL, Walsh SM, Bremer BA, Stephens HE (eds) (2010) Validation of a shorter ALS-specific quality of life instrument: the ALSSQOL-R. Neurology. Lippincott Williams &amp; Wilkins, Philadelphia</Citation></Reference><Reference><Citation>Talbot K, Feneberg E, Scaber J, Thompson AG, Turner MR (2018) Amyotrophic lateral sclerosis: the complex path to precision medicine. J Neurol 265(10):2454&#x2013;2462</Citation><ArticleIdList><ArticleId IdType="pubmed">30054789</ArticleId><ArticleId IdType="pmc">6182683</ArticleId><ArticleId IdType="doi">10.1007/s00415-018-8983-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Appel SH (2019) Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol 18(2):211&#x2013;220</Citation><ArticleIdList><ArticleId IdType="pubmed">30663610</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z-Y, Zhou Z-R, Che C-H, Liu C-Y, He R-L, Huang H-P (2017) Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 88(7):540&#x2013;549</Citation><ArticleIdList><ArticleId IdType="pubmed">28057713</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang E, Lee S, Yi MH, Nan Y, Xu Y, Shin N et al (2017) Expression of granulocyte colony-stimulating factor 3 receptor in the spinal dorsal horn following spinal nerve ligation-induced neuropathic pain. Mol Med Rep 16(2):2009&#x2013;2015</Citation><ArticleIdList><ArticleId IdType="pubmed">28656207</ArticleId><ArticleId IdType="pmc">5561782</ArticleId><ArticleId IdType="doi">10.3892/mmr.2017.6853</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider A, Kr&#xfc;ger C, Steigleder T, Weber D, Pitzer C, Laage R et al (2005) The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115(8):2083&#x2013;2098</Citation><ArticleIdList><ArticleId IdType="pubmed">16007267</ArticleId><ArticleId IdType="pmc">1172228</ArticleId><ArticleId IdType="doi">10.1172/JCI23559</ArticleId></ArticleIdList></Reference><Reference><Citation>Winner B, Winkler J (2015) Adult neurogenesis in neurodegenerative diseases. Cold Spring Harb Perspect Biol 7(4):a021287</Citation><ArticleIdList><ArticleId IdType="pubmed">25833845</ArticleId><ArticleId IdType="pmc">4382734</ArticleId><ArticleId IdType="doi">10.1101/cshperspect.a021287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallner S, Peters S, Pitzer C, Resch H, Bogdahn U, Schneider A (2015) The granulocyte-colony stimulating factor has a dual role in neuronal and vascular plasticity. Front Cell Dev Biol 3:48</Citation><ArticleIdList><ArticleId IdType="pubmed">26301221</ArticleId><ArticleId IdType="pmc">4528279</ArticleId><ArticleId IdType="doi">10.3389/fcell.2015.00048</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama Y, Yagita Y, Oyama N, Terasaki Y, Omura-Matsuoka E, Sasaki T et al (2011) Granulocyte colony-stimulating factor enhances arteriogenesis and ameliorates cerebral damage in a mouse model of ischemic stroke. Stroke 42(3):770&#x2013;775</Citation><ArticleIdList><ArticleId IdType="pubmed">21257824</ArticleId><ArticleId IdType="doi">10.1161/STROKEAHA.110.597799</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt AK, Reich A, Falkenburger B, Schulz JB, Brandenburg LO, Ribes S et al (2015) Adjuvant granulocyte colony-stimulating factor therapy results in improved spatial learning and stimulates hippocampal neurogenesis in a mouse model of pneumococcal meningitis. J Neuropathol Exp Neurol 74(1):85&#x2013;94</Citation><ArticleIdList><ArticleId IdType="pubmed">25470346</ArticleId><ArticleId IdType="doi">10.1097/NEN.0000000000000152</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaziri S, Norowzi M (2012) Investigation of the contamination of local cheeses of Lighvan of Tabriz to coliforms and Escherichia coli in Maragheh. Iran J Microbiol 5(4):23&#x2013;28</Citation></Reference><Reference><Citation>Wright CR, Ward AC, Russell AP (2017) Granulocyte colony-stimulating factor and its potential application for skeletal muscle repair and regeneration. Mediators inflamm 2017:1&#x2013;9</Citation></Reference><Reference><Citation>Zhao W, Beers DR, Appel SH (2013) Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol 8(4):888&#x2013;899</Citation><ArticleIdList><ArticleId IdType="pubmed">23881705</ArticleId><ArticleId IdType="pmc">4126425</ArticleId><ArticleId IdType="doi">10.1007/s11481-013-9489-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajabinejad M, Asadi G, Ranjbar S, Hezarkhani LA, Salari F, Karaji AG et al (2020) Semaphorin 4A, 4C, and 4D: function comparison in the autoimmunity, allergy, and cancer. Gene 746:144637</Citation><ArticleIdList><ArticleId IdType="pubmed">32244055</ArticleId><ArticleId IdType="doi">10.1016/j.gene.2020.144637</ArticleId></ArticleIdList></Reference><Reference><Citation>Phani S, Re DB, Przedborski S (2012) The role of the innate immune system in ALS. Front Pharmacol 3:150</Citation><ArticleIdList><ArticleId IdType="pubmed">22912616</ArticleId><ArticleId IdType="pmc">3418523</ArticleId><ArticleId IdType="doi">10.3389/fphar.2012.00150</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD (2011) The role of immune and inflammatory mechanisms in ALS. Curr Mol Med 11(3):246&#x2013;254</Citation><ArticleIdList><ArticleId IdType="pubmed">21375489</ArticleId><ArticleId IdType="pmc">3182412</ArticleId><ArticleId IdType="doi">10.2174/156652411795243450</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen MD, D&#x2019;Aigle T, Gowing G, Julien J-P, Rivest S (2004) Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J Neurosci 24(6):1340&#x2013;1349</Citation><ArticleIdList><ArticleId IdType="pubmed">14960605</ArticleId><ArticleId IdType="pmc">6730331</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.4786-03.2004</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajabinejad M, Ranjbar S, Afshar Hezarkhani L, Salari F, Gorgin Karaji A, Rezaiemanesh A (2020) Regulatory T cells for amyotrophic lateral sclerosis/motor neuron disease: a clinical and preclinical systematic review. J Cell Physiol 235(6):5030&#x2013;5040</Citation><ArticleIdList><ArticleId IdType="pubmed">31788795</ArticleId><ArticleId IdType="doi">10.1002/jcp.29401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalmarzi RN, Rajabinejad M, Lotfi R (2020) Immune semaphorins: crucial regulatory signals and novel therapeutic targets in asthma and allergic diseases. Eur J Pharmacol 881:173209</Citation><ArticleIdList><ArticleId IdType="pubmed">32454117</ArticleId><ArticleId IdType="doi">10.1016/j.ejphar.2020.173209</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosaddegh R, Ashayeri N, Rezai M, Masoumi G, Vaziri S, Mohammadi F et al (2019) Are serial hematocrit measurements sensitive enough to predict intra-abdominal injuries in blunt abdominal trama? Open Access Emerg Med OAEM 11:9</Citation><ArticleIdList><ArticleId IdType="pubmed">30662287</ArticleId><ArticleId IdType="doi">10.2147/OAEM.S180398</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung T (1998) Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr Opin Hematol 5(3):221&#x2013;225</Citation><ArticleIdList><ArticleId IdType="pubmed">9664164</ArticleId><ArticleId IdType="doi">10.1097/00062752-199805000-00013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafari P, Zarifian A, Alizadeh-Navaei R, Taghadosi M, Rafiei A (2020) Association between polymorphisms of cytokine genes and brucellosis: a comprehensive systematic review and meta-analysis. Cytokine 127:154949</Citation><ArticleIdList><ArticleId IdType="pubmed">31816580</ArticleId><ArticleId IdType="doi">10.1016/j.cyto.2019.154949</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdani Z, Rafiei A, Golpour M, Zafari P, Moonesi M, Ghaffari S (2020) IL-35, a double-edged sword in cancer. J Cell Biochem 121(3):2064&#x2013;2076</Citation><ArticleIdList><ArticleId IdType="pubmed">31633232</ArticleId><ArticleId IdType="doi">10.1002/jcb.29441</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng W (2017) Neuroprotective effects of G-CSF administration in microglia-mediated reactive T cell activation in vitro. Immunol Res 65(4):888&#x2013;902</Citation><ArticleIdList><ArticleId IdType="pubmed">28646409</ArticleId><ArticleId IdType="doi">10.1007/s12026-017-8928-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollari E, Savchenko E, Jaronen M, Kanninen K, Malm T, Wojciechowski S et al (2011) Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis. J Neuroinflammation 8:74</Citation><ArticleIdList><ArticleId IdType="pubmed">21711557</ArticleId><ArticleId IdType="pmc">3146845</ArticleId><ArticleId IdType="doi">10.1186/1742-2094-8-74</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C-H, Huang S-Y, Chen N-F, Feng C-W, Hung H-C, Sung C-S et al (2013) Intrathecal granulocyte colony-stimulating factor modulate glial cell line-derived neurotrophic factor and vascular endothelial growth factor A expression in glial cells after experimental spinal cord ischemia. Neuroscience 242:39&#x2013;52</Citation><ArticleIdList><ArticleId IdType="pubmed">23548516</ArticleId><ArticleId IdType="doi">10.1016/j.neuroscience.2013.02.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K et al (2001) Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28(2):131&#x2013;138</Citation><ArticleIdList><ArticleId IdType="pubmed">11381259</ArticleId><ArticleId IdType="doi">10.1038/88842</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X, Xu Z (2008) Mechanisms of action of angiogenin. Acta Biochim Biophys Sin (Shanghai) 40(7):619&#x2013;624</Citation><ArticleIdList><ArticleId IdType="pubmed">18604453</ArticleId><ArticleId IdType="doi">10.1111/j.1745-7270.2008.00442.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL et al (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34(4):383&#x2013;394</Citation><ArticleIdList><ArticleId IdType="pubmed">12847526</ArticleId><ArticleId IdType="doi">10.1038/ng1211</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin KL, Mao XO, Greenberg DA (2000) Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A 97(18):10242&#x2013;10247</Citation><ArticleIdList><ArticleId IdType="pubmed">10963684</ArticleId><ArticleId IdType="pmc">27841</ArticleId><ArticleId IdType="doi">10.1073/pnas.97.18.10242</ArticleId></ArticleIdList></Reference><Reference><Citation>Pronto-Laborinho AC, Pinto S, de Carvalho M (2014) Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis. Biomed Res Int 2014:947513</Citation><ArticleIdList><ArticleId IdType="pubmed">24987705</ArticleId><ArticleId IdType="pmc">4022172</ArticleId><ArticleId IdType="doi">10.1155/2014/947513</ArticleId></ArticleIdList></Reference><Reference><Citation>Crabtree B, Thiyagarajan N, Prior SH, Wilson P, Iyer S, Ferns T et al (2007) Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. Biochemistry 46(42):11810&#x2013;11818</Citation><ArticleIdList><ArticleId IdType="pubmed">17900154</ArticleId><ArticleId IdType="doi">10.1021/bi701333h</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannesen S, Budeus B, Peters S, Iberl S, Meyer A-L, Kammermaier T et al (2018) Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients. Front Neurol 9:971</Citation><ArticleIdList><ArticleId IdType="pubmed">30534107</ArticleId><ArticleId IdType="pmc">6275232</ArticleId><ArticleId IdType="doi">10.3389/fneur.2018.00971</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash A, Medhi B, Chopra K (2013) Granulocyte colony stimulating factor (GCSF) improves memory and neurobehavior in an amyloid-&#x3b2; induced experimental model of Alzheimer&#x2019;s disease. Pharmacol Biochem Behav 110:46&#x2013;57</Citation><ArticleIdList><ArticleId IdType="pubmed">23756182</ArticleId><ArticleId IdType="doi">10.1016/j.pbb.2013.05.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S, Sava V, Rowe A, Li K, Cao C, Mori T et al (2011) Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson&#x2019;s disease. Neurosci Lett 487(2):153&#x2013;157</Citation><ArticleIdList><ArticleId IdType="pubmed">20951187</ArticleId><ArticleId IdType="doi">10.1016/j.neulet.2010.10.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi G, Varmaziar FR, Karimi M, Rajabinejad M, Ranjbar S, Karaji AG et al (2021) Determination of the transcriptional level of long non-coding RNA NEAT-1, downstream target microRNAs, and genes targeted by microRNAs in diabetic neuropathy patients. Immunol Lett 232:20&#x2013;26</Citation><ArticleIdList><ArticleId IdType="pubmed">33508370</ArticleId><ArticleId IdType="doi">10.1016/j.imlet.2021.01.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittgen T, Pitzer C, Plaas C, Kirsch F, Vogt G, Laage R et al (2012) Granulocyte-colony stimulating factor (G-CSF) improves motor recovery in the rat impactor model for spinal cord injury. PLoS One 7(1):e29880</Citation><ArticleIdList><ArticleId IdType="pubmed">22253813</ArticleId><ArticleId IdType="pmc">3257226</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0029880</ArticleId></ArticleIdList></Reference><Reference><Citation>Diederich K, Sch&#xe4;bitz WR, Minnerup J (2012) Seeing old friends from a different angle: novel properties of hematopoietic growth factors in the healthy and diseased brain. Hippocampus 22(5):1051&#x2013;1057</Citation><ArticleIdList><ArticleId IdType="pubmed">21136518</ArticleId><ArticleId IdType="doi">10.1002/hipo.20904</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Mitchell JD, Moore DH (2012) Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2012(3):Cd001447</Citation><ArticleIdList><ArticleId IdType="pubmed">22419278</ArticleId><ArticleId IdType="pmc">7055506</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, Pitzer C, Dittgen T, Klugmann M, Dupuis L, Schneider A (2011) CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit. Mol Ther 19(2):284&#x2013;292</Citation><ArticleIdList><ArticleId IdType="pubmed">21139572</ArticleId><ArticleId IdType="doi">10.1038/mt.2010.271</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitzer C, Kr&#xfc;ger C, Plaas C, Kirsch F, Dittgen T, M&#xfc;ller R et al (2008) Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain 131(12):3335&#x2013;3347</Citation><ArticleIdList><ArticleId IdType="pubmed">18835867</ArticleId><ArticleId IdType="pmc">2639207</ArticleId><ArticleId IdType="doi">10.1093/brain/awn243</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollari E, Savchenko E, Jaronen M, Kanninen K, Malm T, Wojciechowski S et al (2011) Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis. J Neuroinflammation 8(1):74</Citation><ArticleIdList><ArticleId IdType="pubmed">21711557</ArticleId><ArticleId IdType="pmc">3146845</ArticleId><ArticleId IdType="doi">10.1186/1742-2094-8-74</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando A, Gasco S, de la Torre M, Garc&#xed;a-Redondo A, Zaragoza P, Toivonen JM et al (2017) Granulocyte colony-stimulating factor ameliorates skeletal muscle dysfunction in amyotrophic lateral sclerosis mice and improves proliferation of SOD1-G93A myoblasts in vitro. Neurodegener Dis 17(1):1&#x2013;13</Citation><ArticleIdList><ArticleId IdType="pubmed">27544379</ArticleId><ArticleId IdType="doi">10.1159/000446113</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki R, Tanaka M, Fukunaga M, Tateishi T, Kikuchi H, Motomura K et al (2010) Restoration of microglial function by granulocyte-colony stimulating factor in ALS model mice. J Neuroimmunol 229(1&#x2013;2):51&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">20659772</ArticleId><ArticleId IdType="doi">10.1016/j.jneuroim.2010.07.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Amirzagar N, Nafissi S, Tafakhori A, Modabbernia A, Amirzargar A, Ghaffarpour M et al (2015) Granulocyte colony-stimulating factor for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled study of Iranian patients. J clin neurol (Seoul, Korea) 11(2):164</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2015.11.2.164</ArticleId></ArticleIdList></Reference><Reference><Citation>Pocock K, Suresh N, Suradi Y, Dang S, Harvey B, Cao C et al (2020) An open-label, prospective study evaluating the clinical and immunological effects of higher dose granulocyte colony-stimulating factor in ALS. J Clin Neuromuscul Dis 21(3):127&#x2013;134</Citation><ArticleIdList><ArticleId IdType="pubmed">32073458</ArticleId><ArticleId IdType="doi">10.1097/CND.0000000000000275</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannesen S, Huie JR, Budeus B, Peters S, Wirth AM, Iberl S et al (2021) Modeling and bioinformatics identify responders to g-csf in patients with amyotrophic lateral sclerosis. Front Neurol 12:616289</Citation><ArticleIdList><ArticleId IdType="pubmed">33815246</ArticleId><ArticleId IdType="pmc">8012841</ArticleId><ArticleId IdType="doi">10.3389/fneur.2021.616289</ArticleId></ArticleIdList></Reference><Reference><Citation>Iberl S, Meyer A-L, M&#xfc;ller G, Peters S, Johannesen S, Kobor I et al (2019) Effects of continuous high-dose G-CSF administration on hematopoietic stem cell mobilization and telomere length in patients with amyotrophic lateral sclerosis&#x2013;a pilot study. Cytokine 120:192&#x2013;201</Citation><ArticleIdList><ArticleId IdType="pubmed">31100684</ArticleId><ArticleId IdType="doi">10.1016/j.cyto.2019.05.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassinger J, Khomenko A, Hart C, Baldaranov D, Johannesen SW, Mueller G et al (2014) Safety and feasibility of long term administration of recombinant human granulocyte-colony stimulating factor in patients with amyotrophic lateral sclerosis. Cytokine 67(1):21&#x2013;28</Citation><ArticleIdList><ArticleId IdType="pubmed">24680478</ArticleId><ArticleId IdType="doi">10.1016/j.cyto.2014.02.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarella C, Rutella S, Gualandi F, Melazzini M, Scim&#xe8; R, Petrini M et al (2010) Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte&#x2013;colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial. Cytotherapy 12(1):50&#x2013;59</Citation><ArticleIdList><ArticleId IdType="pubmed">19878077</ArticleId><ArticleId IdType="doi">10.3109/14653240903300682</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, Kastner S, Chatzikonstantinou E, Pitzer C, Plaas C, Kirsch F et al (2015) Gene expression changes in spinal motoneurons of the SOD1G93A transgenic model for ALS after treatment with G-CSF. Front Cell Neurosci 8:464</Citation><ArticleIdList><ArticleId IdType="pubmed">25653590</ArticleId><ArticleId IdType="pmc">4299451</ArticleId><ArticleId IdType="doi">10.3389/fncel.2014.00464</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumenko N, Pollari E, Kurronen A, Giniatullina R, Shakirzyanova A, Magga J et al (2011) Gender-specific mechanism of synaptic impairment and its prevention by GCSF in a mouse model of ALS. Front Cell Neurosci 5:26</Citation><ArticleIdList><ArticleId IdType="pubmed">22180738</ArticleId><ArticleId IdType="pmc">3238042</ArticleId><ArticleId IdType="doi">10.3389/fncel.2011.00026</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas JE, Caro E, Gutierrez-Jimenez E, Segura JJ (2009) Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 11(1):26&#x2013;34</Citation><ArticleIdList><ArticleId IdType="pubmed">19191058</ArticleId><ArticleId IdType="doi">10.1080/14653240802644651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez HR, Molina-Lopez JF, Gonz&#xe1;lez-Garza MT, Moreno-Cuevas JE, Caro-Osorio E, Gil-Valadez A et al (2012) Stem cell transplantation in amyotrophic lateral sclerosis patients: methodological approach, safety, and feasibility. Cell Transplant 21(9):1899&#x2013;1907</Citation><ArticleIdList><ArticleId IdType="pubmed">23356668</ArticleId><ArticleId IdType="doi">10.3727/096368911X582769</ArticleId></ArticleIdList></Reference><Reference><Citation>Duning T, Schiffbauer H, Warnecke T, Mohammadi S, Floel A, Kolpatzik K et al (2011) G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial. PLoS One 6(3):e17770</Citation><ArticleIdList><ArticleId IdType="pubmed">21423758</ArticleId><ArticleId IdType="pmc">3056779</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0017770</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman N, Tan LY, Krieger C, M&#xe4;dler B, Mackay A, Mackenzie I et al (2008) Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle Nerve Off J Am Assoc Electrodiagn Med 37(5):620&#x2013;625</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20951</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Wang L, Fu Y, Song H, Zhao H, Deng M et al (2009) Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10(5&#x2013;6):430&#x2013;431</Citation><ArticleIdList><ArticleId IdType="pubmed">19922135</ArticleId><ArticleId IdType="doi">10.3109/17482960802588059</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mora G, La Bella V, Caponnetto C, Mancardi G, Sabatelli M et al (2011) Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. Muscle Nerve 43(2):189&#x2013;195</Citation><ArticleIdList><ArticleId IdType="pubmed">21254083</ArticleId><ArticleId IdType="doi">10.1002/mus.21851</ArticleId></ArticleIdList></Reference><Reference><Citation>Nefussy B, Artamonov I, Deutsch V, Naparstek E, Nagler A, Drory VE (2010) Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: a pilot study. Amyotroph Lateral Scler 11(1&#x2013;2):187&#x2013;193</Citation><ArticleIdList><ArticleId IdType="pubmed">19449238</ArticleId><ArticleId IdType="doi">10.3109/17482960902933809</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>